Efficacy of defocus incorporated multiple segments (DIMS) lenses and low-dose atropine on retarding myopic shift among premyopic preschoolers: Protocol for a prospective, multicenter, randomized controlled trial

PLoS One. 2024 Dec 31;19(12):e0312935. doi: 10.1371/journal.pone.0312935. eCollection 2024.

Abstract

Background: Myopia has been a rising problem globally. Early-onset myopia significantly increases the risk of high myopia later in life. Despite the proven benefits of increased outdoor time, optimal strategies for preventing early-onset myopia in premyopic children need further investigation.

Methods: This randomized controlled trial aims to evaluate the efficacy of optical (Defocus Incorporated Multiple Segments [DIMS] spectacle lenses) and pharmacological (0.01% atropine eye drops) interventions in preventing myopia among premyopic preschoolers. We will recruit 234 premyopic, asymptomatic 5-to-6-year-old children who will have received cycloplegic autorefraction examination in a countywide kindergarten eye care program in Yilan County, Taiwan. Eligible participants will be randomly assigned to DIMS spectacles (n = 78), 0.01% atropine (n = 78), or usual care (n = 78). In the DIMS group, preschoolers will be instructed to wear spectacles at home before entering elementary school but to wear them all the time after school entry. In the atropine group, subjects will be given 0.01% atropine eyedrops nightly throughout the study period. All participants will be encouraged to spend time outdoors for 2 hours every day. During the 18-month study period, cycloplegic spherical equivalent (SE) refraction, axial length, and subfoveal choroidal thickness will be measured every three months, and parents-administered questionnaires regarding risk factors for myopia will be performed every nine months.

Primary outcome: The change in mean cycloplegic SE.

Secondary outcomes: The cumulative percentage of incident myopia, the cumulative percentage of a fast myopic shift of SE, and the changes in mean axial length.

Other pre-specified outcomes: The time to myopia onset, alteration in subfoveal choroidal thickness, and levels of near work/outdoor activities.

Trial registration: This study is registered at www.clinicaltrials.gov as NCT06200194.

Conclusion: This trial will provide insights into myopia prevention strategies and inform new eye care policies for early identification and intervention in premyopic preschoolers.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study

MeSH terms

  • Atropine* / administration & dosage
  • Atropine* / therapeutic use
  • Child
  • Child, Preschool
  • Eyeglasses*
  • Female
  • Humans
  • Male
  • Mydriatics / administration & dosage
  • Mydriatics / therapeutic use
  • Myopia* / prevention & control
  • Ophthalmic Solutions / administration & dosage
  • Prospective Studies
  • Refraction, Ocular / drug effects
  • Treatment Outcome

Substances

  • Atropine
  • Ophthalmic Solutions
  • Mydriatics

Associated data

  • ClinicalTrials.gov/NCT06200194

Grants and funding

This study was supported by grants from National Yang Ming Chiao Tung University (RD2024-003) and National Science and Technology Council, Republic of China (NSTC 113-2314-B-A49-022). This study was supported by grants from National Yang Ming Chiao Tung University (RD2024-003) and the National Science and Technology Council, Republic of China (NSTC 113-2314-B-A49-022). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.